Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intracuff Dexmedetomidine Versus Alkalinized Lidocaine for Reducing Peri-Extubation Cough and Hemodynamic Responses in Elderly Patients: A Randomized Double-Blind Controlled Trial

NCT07916246 is registered in ClinicalTrials.gov with Beni-Suef University as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07916246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Intracuff Dexmedetomidine Versus Alkalinized Lidocaine for Reducing Peri-Extubation Cough and Hemodynamic Responses in Elderly Patients: A Randomized Double-Blind Controlled Trial
Lead sponsor
Beni-Suef University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
May 31, 2027
Enrollment
184 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

airway complication of anesthesia, emergence delirium, anesthesia, hemodynamic instability, postoperative complications

Arms

As registered; 2 arms.

  • Group DEX (Intracuff Dexmedetomidine) ExperimentalDexmedetomidine

    Elderly surgical patients whose endotracheal tube (ETT) cuff is filled with a dexmedetomidine solution (16 µg total dose in 4 mL normal saline) immediately following tracheal intubation. Cuff pressure is maintained at 20-25 cmH2O throughout the surgery.

  • Group LIDO (Intracuff Alkalinized Lidocaine) Active comparatorAlkalinized Lidocaine

    Elderly surgical patients whose endotracheal tube (ETT) cuff is filled with an alkalinized lidocaine solution (40 mg lidocaine + 8.4% sodium bicarbonate, total volume 4 mL) immediately following tracheal intubation. Cuff pressure is maintained at 20-25 cmH2O throughout the surgery.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Incidence of Smooth Extubation During the first 60 seconds post-extubation

    Proportion (percentage) of participants in each group achieving smooth extubation, defined as a cough score of 0 or 1 on a validated 4-point scale during the first 60 seconds after tube removal. Assessment begins continuously at the exact moment the endotracheal tube cuff passes through the vocal cords (marked by stopwatch).

    Cough Scale:

    * 0 = No cough
    * 1 = Single mild cough
    * 2 = Moderate coughing (2-3 coughs)
    * 3 = Severe coughing (≥4 coughs or bucking)

    A score of 0-1 indicates smooth extubation (desirable outcome).

Lead sponsor's other trials

Beni-Suef University, most recent start first.

Similar trials

Same condition (Emergence Delirium) and phase, most recent start first.